Immunic (IMUX)
Develops oral small-molecule candidates for multiple sclerosis and other inflammatory or autoimmune diseases.
$11.08
vs last close+0.24 (+2.26%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 51 days
EPS estimate
−$0.94
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$2.50−$2.50−$2.00−$1.30−$1.20−$1.08−$0.80Pending
Estimate−$0.22−$2.50−$1.58−$0.18−$0.90−$0.71−$1.16−$0.94
Surprise−1,036.4%0.0%−26.7%−622.2%−33.3%−52.1%+31.0%—
RevenueReportedEstimate
Apr '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate$6.0K———————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.53 | — | — |
| Sep 2028 | $1.50 | — | — |
| Jun 2028 | $1.53 | — | — |
| Mar 2028 | $0.83 | — | — |
| Dec 2027 | −$0.69 | — | — |
| Sep 2027 | −$0.63 | — | — |
| Jun 2027 | −$0.64 | — | — |
| Mar 2027 | −$0.62 | — | — |
| Dec 2026 | −$0.80 | — | — |
| Nov 2026 | −$0.94 | — | — |
| Aug 2026 | −$1.16 | −$0.80 | +31.0% |
| May 2026 | −$0.71 | −$1.08 | −52.1% |
| Feb 2026 | −$0.90 | −$1.20 | −33.3% |
| Nov 2025 | −$0.18 | −$1.30 | −622.2% |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.53 | — | — | $117.7M | — | — | — |
| Sep 2028 | $1.50 | — | — | $113.2M | — | — | — |
| Jun 2028 | $1.53 | — | — | $113.2M | — | — | — |
| Mar 2028 | $0.83 | — | — | $108.6M | — | — | — |
| Dec 2027 | −$0.69 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.63 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.64 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.62 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.80 | — | — | $0 | — | — | — |
| Nov 12, 2026 | −$0.94 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$1.16 | −$0.80 | +31.0% | — | — | — | +9.8% |
| May 13, 2026 | −$0.71 | −$1.08 | −52.1% | — | — | — | −2.2% |
| Feb 26, 2026 | −$0.90 | −$1.20 | −33.3% | — | — | — | +7.6% |
| Nov 13, 2025 | −$0.18 | −$1.30 | −622.2% | — | — | — | −6.2% |
| Aug 7, 2025 | |||||||
| May 15, 2025 | |||||||
| Apr 3, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 26, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 2, 2020 | |||||||
| May 8, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| Apr 10, 2019 | |||||||
| Mar 4, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 13, 2018 | |||||||
| Oct 25, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 7, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 2, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Jul 30, 2015 |